血液凝固阻止
Anti-blood clotting
Anticoagulation du sang
Blutgerinnungshemmung

First PT/INR home self-testing device with Bluetooth technology enabling remote care programs for anticoagulated patients:

CoaguChek INRange system enhances patient engagement with healthcare providers for optimal therapy management.

Roche announced that it has launched the CoaguChek® INRange system in countries accepting the CE Mark (not available in all countries).

The CoaguChek INRange system is the first Bluetooth enabled PT/INR home health device that helps patients and their healthcare providers (HCPs) have greater control over their coagulation status and the ability to monitor Vitamin K Antagonist (VKA) therapy.

Patient self-testing with CoaguChek INRange sets a new standard of care by enabling HCPs to monitor patient PT/INR data, while reducing visits to the lab.

Frequent self-testing offers both clinical and patient benefit:

+ monitoring therapy spend more time in their therapeutic range
+ results in lower incidence of stroke or bleeding
+ 50–60% of patients can be expected to remain in their target range

Millions of people worldwide are taking Vitamin K Antagonists (VKAs) for a variety of indications or conditions, such as atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE), and the presence of a mechanical heart valve (MHV).

___________________________________________________

今日も一日よろしくお願いします。

Sepp Faessler

Implementing your ideas for the future, fascinates us!

+ Business development.
+ Global dedication.
+ Swissness.
+ Do business in Europe.
+ High quality services.
+ Free 1/2 hour Phone - Skype Consultation.
+ コンサルタント・EU スイス 素晴らしい情報、答えと結果!
+ ３０分間 の電話 - スカイプ コンサルティングは無料。

ご質問は...

http://www.swf-technology.ch/
___________________________________________________